Acne Treatment With Sulfur Ointment
NDC Package 24286-1573-2
Package Information
Acne Treatment With Sulfur (sulfur) ointment is cleanse the skin thoroughly before applyingcover the entire affected area with a thin layerleave on for 10 minutesthoroughly remove with waterbecause excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctorif bothersome dryness or peeling occurs, reduce application to once a day or every other day. This formulation utilizes a ointment delivery system. Marketed by Dlc Laboratories, Inc., this product is identified by NDC 24286-1573 and is authorized under FDA application M006.
Identification & Billing
- RxCUI: 417863 - sulfur 5 % Topical Ointment
- RxCUI: 417863 - sulfur 0.05 MG/MG Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 24286 - Dlc Laboratories, Inc.
- 24286-1573 - Acne Treatment With Sulfur
- 24286-1573-2 - 6 g in 1 JAR
- 24286-1573 - Acne Treatment With Sulfur
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (24286-1573). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 24286-1573-2 identifies a specific commercial package of 6 g in 1 jar of Acne Treatment With Sulfur, a human over the counter drug labeled by Dlc Laboratories, Inc.. This ointment is formulated for topical use and contains sulfur as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dlc Laboratories, Inc. on August 16, 2019. The current certification is valid through December 31, 2027.
How is this Dlc Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 24286157302. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.